Genmab — Maj 2018

[Bella1]

Det ser ud til et rimeligt luk. Så, rigtig god weekend, og husk lys i vinduerne....

[Bulder]

Den værste lukkeauktion nogensinde. 6 kr. ned. Uhørt!

[Bella1]

16.50 kr., total uhørt!

[Solsen]

Det er kun penge. Nyd det gode vejr !

[AaBforever]

Du har ret Solsen....meeeen det er godt MED penge og sommervejr...go`weekend til alle!

[Solsen]

De du har stående i aktier kan du alligevel ikke bruge

[hda]

Dickens ? http://borsen.dk/nyheder/avisen/artikel/11/197836/artikel.html?utm_source=forside&utm_campaign=nyhed_05

[peter12]

Et par nye videoer http://www.oncologytube.com/video/managing-plasma-cell-leukemia-pls-imids-alkylating-agents-and-antibodies/10003839 https://www.youtube.com/watch?v=uar8CEMye4Q

[peter12]

GNMSF er OTC? Iflg Finanstilsynet var der 4,1% shorts sidst i marts i GEN

[rex_pacis]

nej, jeg kender kun denne https://oasm.finanstilsynet.dk/dk/soegeresultat.aspx?t=Genmab for danske, som du vist også bruger

[Helge_LarsenPI-redaktør]

God morgen.:-)

[Helge_LarsenPI-redaktør]

Jeg kan godt bruge mange flere spørgsmål til Q&A på onsdag.

[Parasitism]

God morgen

[bibob]

God morgen

[Doc4]

God morgen Genmabbere. De sidste 14 dages scanning af videnskabelige artikler - lidt Dara-soduku. Til sammenligning er der ikke produceret CAR-T artikler af stor interesse for nuværende.

[Doc4]

Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus erythematosus.
Most importantly, our data show for the first time that daratumumab effectively depletes plasma cells/plasmablasts in PBMC from patients with SLE and RA in a dose-dependent manner ex vivo.
http://www.ncbi.nlm.nih.gov/pubmed/29720240

[Doc4]

Daratumumab, lenalidomide, and dexamethasone in East Asian patients with relapsed or refractory multiple myeloma: subgroup analyses of the phase 3 POLLUX study.
The efficacy and safety profiles of targeted anticancer therapies in East Asian patients may differ from those of the overall study populations in clinical trials14,15. To understand the impact of DRd vs. Rd in the East Asian patient population, we performed subanalyses of POLLUX data to evaluate the efficacy and safety of DRd vs. Rd in

[Doc4]

...East Asian (Japanese, Korean, and Taiwanese) patients as well as in only Japanese patients.
Reslutatet var enslydende med POLLUX generelt.
East Asian (Japanese, Korean, and Taiwanese) patients as well as in only Japanese patients.
Reslutatet var enslydende med POLLUX generelt.
East Asian (Japanese, Korean, and Taiwanese) patients as well as in only Japanese patients.
Reslutatet var enslydende med POLLUX generelt.
http://www.ncbi.nlm.nih.gov/pubmed/29712896

[Doc4]

Immunomodulatory effects of CD38-targeting antibodies. God indblik i den avancerede molekylære mekanisme + nye muligheder.
https://sci-hub.hk/10.1016/j.imlet.2018.04.005

[Doc4]

Durable treatment response of relapsing CNS plasmacytoma using intrathecal chemotherapy, radiotherapy, and Daratumumab
Although the therapy of CNS EMM is dif- ficult, the present case illustrates that a durable response (19 months) can be achieved by using systemic daratumumab therapy, IT chemotherapy, and craniospinal radiotherapy, which compares favorably to the reported literature.https://sci-hub.hk/10.1002/ccr3.1451